Skip to main content
. 2023 Mar 14;28(7):e508–e519. doi: 10.1093/oncolo/oyad040

Figure 3.

Figure 3.

Frequency of pathogenic gene mutations in the total cohort (a) and NF2-mutated kidney tumors (b).